The anti snake venom crisis in Africa: a suggested manufacturers product guide.
Considerable attention has been given to the shortage of anti snake venom in Africa. The current supply is reported to rest at crisis levels, and considerable attention has been given to reporting the crisis. What has been absent is a recommended list of anti snake venoms that suppliers can produce in order to alleviate the problem. Suppliers who may want to enter the market and provide new anti snake venoms are hampered by a lack of knowledge of which to provide, where to source the venoms necessary for production, and the likely volume levels required. Snakebite epidemiology is recognized as being poor, particularly in estimating the number of envenomations. Snakebite authorities and organizations such as the World Health Organisation have provided lists of medically significant species, but these are inadequate as a guide to production. This paper proposes a list of anti snake venoms that could be produced by suppliers and crucially lists relevant species by geographical area, venom sources for the target species, and likely production volumes to enable suppliers to develop a confident forecast of demand to ensure sustainability.
Simpson
Ian D
ID
Pakistan Medical Research Council, Islamabad, Pakistan. iandsimpson@gmail.com
Blaylock
Roger S M
RS
D000349:Africa / Q000453:epidemiology; D000818:Animals; D000997:Antivenins / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D003906:Developing Countries; D006801:Humans; D011634:Public Health; D012909:Snake Bites / Q000453:epidemiology / Q000628:therapy*; D012910:Snake Venoms / Q000037:antagonists & inhibitors*; D013045:Species Specificity; D014944:World Health Organization
D000997:Antivenins; D012910:Snake Venoms